Edition:
United States

United Therapeutics Corp (UTHR.OQ)

UTHR.OQ on NASDAQ Stock Exchange Global Select Market

168.16USD
17 Feb 2017
Change (% chg)

-- (--)
Prev Close
$168.16
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
247,070
52-wk High
$168.81
52-wk Low
$97.70

UTHR.OQ

Chart for UTHR.OQ

About

United Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products for the treatment of chronic and life-threatening conditions. Its therapeutic products and product candidates include Prostacyclin Analogues, Phosphodiesterase Type 5 (PDE-5) Inhibitor and... (more)

Overall

Beta: 1.47
Market Cap(Mil.): $7,132.59
Shares Outstanding(Mil.): 42.42
Dividend: --
Yield (%): --

Financials

  UTHR.OQ Industry Sector
P/E (TTM): 11.33 47.80 29.39
EPS (TTM): 14.84 -- --
ROI: 39.82 -4.08 13.06
ROE: 42.54 4.84 14.19

BRIEF-United Therapeutics reports Q3 EPS $3.50

* United therapeutics corporation reports third quarter 2016 financial results

Oct 27 2016

More From Around the Web

Earnings vs. Estimates